SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-032721
Filing Date
2022-11-17
Accepted
2022-11-17 09:25:07
Documents
1
Period of Report
2022-11-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4998
  Complete submission text file 0001493152-22-032721.txt   6639
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

IRS No.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2220 SOUTHERLAND AVE KNOXVILLE TN 37919
Business Address
Pershing Edward (Reporting) CIK: 0001689739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 221396970